| 注册
首页|期刊导航|中国药业|苏黄止咳胶囊佐治上呼吸道感染后反复咳嗽60例临床研究

苏黄止咳胶囊佐治上呼吸道感染后反复咳嗽60例临床研究

陆萍 苏斌虓

中国药业Issue(15):23-24,25,3.
中国药业Issue(15):23-24,25,3.

苏黄止咳胶囊佐治上呼吸道感染后反复咳嗽60例临床研究

Upper Respiratory Tract Infection Cough Treatment Efficacy of Suhuang Cough Capsules in 60 Cases

陆萍 1苏斌虓2

作者信息

  • 1. 中国人民解放军 68090 部队门诊部,陕西 西安 710016
  • 2. 中国人民解放军第四军医大学第一附属医院,陕西 西安 710032
  • 折叠

摘要

Abstract

Objective To investigate the treatment of the Soviet Union after the Su Huang Capsule respiratory infection cough cough ef-ficacy and safety evaluation. Methods 120 cases of upper respiratory tract infection cough patients according to the random number table will be included in this group were randomly divided into treatment group ( n = 60) and control group ( n = 60) . The treatment group received capsules Su Huang cough treatment, the control group received dextromethorphan oral therapy, were treated for 10 d. Results The overall response rate (95. 00% ) was significantly higher (81. 67% ), and has a significant ( P < 0. 05) . The treatment group cough scores were significantly lower than the control group, and has a significant ( P < 0. 05) . The treatment group scores day-time and nighttime cough cough symptom score was significantly lower than the control group, and both have a significant ( P < 0. 05). The EOS, NEU, LYM number has a significant ( P < 0. 05) . No obvious adverse reactions during treatment groups. Conclusion Su Huang cough Capsule respiratory infection after the treatment effect is significant, safe and reliable, has important clinical significance, worthy of further applications.

关键词

苏黄止咳胶囊/抗炎治疗/上呼吸道感染/咳嗽/临床疗效

Key words

Su Huang cough capsule/anti - inflammatory therapy/upper respiratory tract infection/cough/clinical efficacy

分类

医药卫生

引用本文复制引用

陆萍,苏斌虓..苏黄止咳胶囊佐治上呼吸道感染后反复咳嗽60例临床研究[J].中国药业,2015,(15):23-24,25,3.

中国药业

1006-4931

访问量0
|
下载量0
段落导航相关论文